Drugs / AEG33773
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00891683 Comparator | Mar → Dec 2009 | chronic pain syndrome, diabetic polyneuropathy | Aegera Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AEG33773 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00891683 ↗ |
| Route | Oral | “Capsules will be taken by mouth, over 28 consecutive days” NCT00891683 ↗ |